Not an actual patient. Symptoms Illustrated.

Seborrheic Dermatitis?

ORYVE IT
RELIEVE IT

ZORYVE  has the power and
versatility to be your go-to topical.1
Not a steroid. No boxed warning
ZORYVE (roflumilast) Topical Foam 0.3%ZORYVE (roflumilast) Topical Foam 0.3%
Simple once-daily treatmentSimple once-daily treatment

For age 9+

“

After living with the itchy and flaky skin for years I finally said, ‘enough is enough’ and went to talk with my dermatologist.”

Simone Biles: The New Face of ZORYVE

Simone’s journey with seborrheic dermatitis led her to her dermatologist. Now, she’s partnering with ZORYVE to help inspire others to speak up about their skin conditions.

Read her story

Simone Biles is a real patient treated with ZORYVE who was compensated for her time spent sharing her experience. Individual results may vary.

Dramatic skin clearance
and rapid itch relief1

See Efficacy Data

Established safety profile and
well tolerated for the scalp and body1

View Safety Data

Simple, once-daily
treatment1

Discover Elegant Formulations

ZORYVE foam has the potential to become the standard of care for seborrheic dermatitis.”

—Arcutis Chief Medical Officer Patrick Burnett, MD, PhD, FAAD

ZORYVE (roflumilast) Topical Foam 0.3%
ZORYVE (roflumilast) Topical Foam 0.3%
ZORYVE Direct, Patient Access Support Made Easy

Committed to affordable patient access
across all indications

The ZORYVE Direct Savings Program helps eligible, commercially insured patients get access and start ZORYVE treatment quickly and easily*†

Patient Access Support

Savings Program

Adherence Support

Learn About Patient
Access Support

*Prescriptions will be delivered to the patient 1–2 days after processing.

†Subject to eligibility criteria and maximum program limitation. This offer is not valid for patients without commercial drug insurance or whose prescription claims are eligible to be reimbursed, in whole or in part, by any government program. Please see Terms and Conditions.